At 26, most people are juggling rent, careers, and group chats, not life-or-death medical decisions. So when a young woman ...

Stage 3 colorectal cancer patients with MRD benefit from Celebrex addition to chemotherapy, showing a 40% risk reduction in death for Signatera-positive patients. Celebrex improved disease-free and ...